종목/DQWS
예정된 실적 발표가 아직 잡히지 않았습니다.
DSwiss, Inc., a biotech nutraceutical company, provides healthcare, skincare, and personal care products in Malaysia, Singapore, Indonesia, Australia, Hong Kong, Taiwan, Macau, and China. It supplies health and beauty products, including weight management beverages, anti-aging creams, and immune system enhancers. The company also provides private label manufacturing services for nutraceutical and skincare/personal care ODM/OEM products; pet wellness supplements; and pet-care products, as well as medical consumable supplies, such as disposable stretcher cover and bedsheet, masks, body infrared thermometers, sanitizer, protective goggles, surgical gloves, isolation suit, industrial disinfectant, and protection surgical and medical gown. In addition, it offers OEM/ODM/OBM services, such as DSwiss quantum magnetic analyzer and DNA genotyping services; Eyecare; and biotechnology research channel services. DSwiss, Inc. was incorporated in 2015 and is headquartered in Kuala Lumpur, Malaysia.
| 발표일 | 분기 | EPS 예상 | EPS 실제 | Surprise | 매출 실제 | 발표 직후 반응 |
|---|---|---|---|---|---|---|
| 5월 13일 (수) | 2026 Q1 | — | — | — | — | — |
| 3월 31일 (화) | 2025 Q4 | — | — | — | — | 0.0% |
| 100% (4/4) |
| PG | P&G | 347B | −0.8% | 75% (3/4) |
| PM | 필립 모리스 인터내셔널 | 282B | +4.1% | 100% (4/4) |
애널리스트 의견이 수집되지 않았습니다.